Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0-B1 hepatocellular carcinoma.

Feiqian WangKazushi NumataAtsuya TakedaKatsuaki OgushiHiroyuki FukudaKoji HaraMakoto ChumaTakahisa EriguchiYuichirou TsurugaiShin Maeda

Published in: PloS one (2021)

The short-term administration of RFA and SBRT to the same BCLC stage 0-B1 patients may be feasible and effective because of their good prognosis and safety.

Keyphrases

radiofrequency ablation
end stage renal disease
radiation therapy
chronic kidney disease
ejection fraction
early stage
peritoneal dialysis
prognostic factors